Poging GOUD - Vrij
Faster drug trials in works as India eyes export gains
Mint Mumbai
|September 04, 2025
New drugs may reach chemists quicker and clinical trials kick off earlier, with the Union health ministry drafting rules to cut the time to process approvals by half and help India expand its footprint in the $1.55 billion global clinical trials industry.
The proposed changes will streamline the process for testing licences and certain studies by replacing the old licensing system with a faster online notification system, the health ministry said on Wednesday.
This will require an amendment to India's New Drugs and Clinical Trials Rules, 2019, potentially reducing the application processing time from 90 to 45 working days.
A key change proposed in the draft New Drugs and Clinical Trials (Amendment) Rules, 2025 allows firms to start studies on drugs meant for export with an online notification if the product's been approved in major markets such as the US, UK, EU, Japan, Australia and Canada.
These studies will be limited to a maximum of 48 healthy adult volunteers.
The ministry said the changes aim to reduce licence applications by about 50%.
The public has 30 days to submit comments.
Dit verhaal komt uit de September 04, 2025-editie van Mint Mumbai.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Mumbai
Mint Mumbai
Tobacco cess set to expire, enter health and national security cess
Finance minister Nirmala Sitharaman will introduce a bill in Lok Sabha on Monday to levy a new cess for public health and national security, replacing the GST compensation cess on tobacco, which will lapse when the Centre completes repayment of the loans raised to compensate states.
2 mins
December 01, 2025
Mint Mumbai
Battery PLI may get new spark as rules set to ease
Scheme saw limited success; 50GWh capacity by Dec 2024 goal fell far short
3 mins
December 01, 2025
Mint Mumbai
China used to be a cash cow for western companies. Now it’s a test lab.
For Western companies in China, a new reality has set in: The easy money is gone and competition is only getting fiercer.
4 mins
December 01, 2025
Mint Mumbai
BEHIND THE GLOSSY REPORT: THE MAKE BELIEVE ESG WORLD
Recently, the Sebi chairperson made a distinction that should make every company board squirm, Speaking at the “Gatekeepers of Governance’ summit, Tuhin Kanta Pandey separated “compliance” from “governance” in a way that was both elegant and damning.
2 mins
December 01, 2025
Mint Mumbai
New safety, emission rules spell riches for parts firms
Anti-lock brakes? Sound alerts for EVs? Ever-changing emission norms? For India’s nimble auto parts makers, every new regulation to raise safety and lower pollution is opening up business avenues.
3 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Mint Mumbai
Smart GDP growth casts shadow over December rate cut
The Reserve Bank of India’s (RBI's) Monetary Policy Committee (MPC) is widely expected to keep the policy rate unchanged on 5 December, even as a sizable minority of economists argues that the space created by softening inflation and moderating nominal growth warrants another rate cut.
2 mins
December 01, 2025
Mint Mumbai
Why MF vendors haven't grown as fast as MF assets
A rising tide does not lift all boats—an adage that mutual fund distributors will vouch for.
4 mins
December 01, 2025
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Listen
Translate
Change font size

